Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 18 and up

Doxycycline to treat post-operative seromas after orthopedic surgery

Official title: The Role of Doxycycline in the Management of Postoperative Seromas: A Pilot Study

Run by University of Miami · NCT07498010 · Data updated 2026-11-12

A Phase 2 trial tests whether doxycycline can help close seromas that form after orthopedic procedures by causing the cavity to scar and seal shut.

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment10 (estimated)
SponsorUniversity of Miami
Academic / other
Locations1 site (Coral Gables, Florida)
StatusRecruiting
StartedMay 31, 2026
Main results expectedMay 10, 2027
Study endsOctober 1, 2027
Registry record updatedJuly 9, 2026
Trial IDNCT07498010 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with imaging-confirmed seroma after an orthopedic procedure who are able to provide informed consent and comply with study procedures.

Probably not a fit

Patients with contraindications to doxycycline, significant liver or kidney impairment, or those unlikely to complete follow-up may not benefit or participate.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This Phase 2 interventional study explores doxycycline sclerotherapy as a treatment for seromas that occur after orthopedic surgery. Eligible adults with imaging-confirmed seromas will receive doxycycline in an effort to induce fibrosis and eliminate the potential space. The approach aims to reduce fluid recurrence, support wound healing, and improve postoperative recovery. Outcomes will focus on seroma resolution, safety, and any impact on rehabilitation progress. The study is conducted at the University of Miami with no listed collaborators.

Why it matters

Potential benefit: If successful, patients may experience easier seroma resolution, less pain, and quicker return to normal rehabilitation.

How similar studies have gone: Doxycycline sclerotherapy has been used in other settings to induce fibrosis, with prior success reported in similar contexts, though specific application to orthopedic seromas is less established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient with seroma formation following orthopedic procedure
* \>18 years old
* Willing and able to provide informed consent
* Pre-operative imaging (US, CT) demonstrating seroma formation

Exclusion Criteria:

* Pregnancy or lactation
* Age \<18 years
* Known allergy to tetracyclines
* Significant hepatic or renal dysfunction (Alanine Aminotransferase (ALT)/Aspartate Aminotransferase (AST) \>3× Upper Limit of Normal (ULN), Creatinine Clearance (CrCl \<30 mL/min)
* History of photosensitivity or photodermatosis
* Concurrent isotretinoin or retinoid therapy
* Current use of anticoagulants or immunosuppressants
* Active GI ulceration or esophageal disease
* Any condition likely to impair adherence or drug absorption (e.g., malabsorption syndromes)

Where it's running

  • University of Miami
    Coral Gables, Florida, United States
    Recruiting

Study contacts

  • Principal investigator: Colin McNamara, MD — University of Miami
  • Study coordinator: Robert E Carrier, DO
  • Email: rec182@miami.edu
  • Phone: 413-478-8417

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.